Skip to Main Content

Paper Details

Molecular Characterization of Acquired Resistance to KRASG12C-EGFR Inhibition in Colorectal Cancer.
Cancer Discov
25
2023
DNA, EGFR, ERK, KRAS, KRAS G12C, cell lines, colorectal cancer, mTOR, patient, patient samples, patient-derived xenografts, patients, resistant cells
Author NameAffiliation
Arnaud Da Cruz PaulaMemorial Sloan Kettering Cancer Center
Britta WeigeltMemorial Sloan Kettering Cancer Center
Michael F BergerMemorial Sloan Kettering Cancer Center
Michael F BergerKravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center
Nicholas D SocciKravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center
Gregory J RielyMemorial Sloan Kettering Cancer Center
Jorge S Reis-FilhoMemorial Sloan Kettering Cancer Center
Elisa de StanchinaMemorial Sloan Kettering Cancer Center
  • 1 - 8

Datasets

Release 1.2